Vigabatrin is a new antiepileptic sold as Sabril® in the US, Canada, Mexico and the United Kingdom and as Sabrilex® in Denmark. The drug is used as an adjunctive treatment of complex partial seizures in adults and for infantile spasms in pediatric patients one month to two years of age. This certified Snap-N-Spike® solution standard is suitable for use in LC/MS or GC/MS applications including forensic analysis, clinical toxicology, urine drug testing, or pharmaceutical research.